Clearside Biomedical, Inc. Common Stock

Go to Clearside Biomedical, Inc. Common Stock Website

$0.44

0.05 (14.32%)
Live
Previous Close

$0.4151

Day Range

$0.3995 - $0.4625

Previous Day Range

$0.38 - $0.42

Market Cap

$29.8 million USD

Day Vol.

858266

Previous Day Vol.

826834

Currency

USD

Primary Exchange

Nasdaq

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injecti...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Multiple companies are exploring strategic options including potential mergers, acquisitions, and restructuring, with some facing financial challenges like bankruptcy and operational reviews.

Related tickers: KVUE, CLSD, PRSO, UNP.

Read Full Article

The age-related macular degeneration (AMD) market is expected to grow due to the launch of new therapies and increased healthcare spending. Dry AMD and wet AMD are the two main types, with new treatments in development for both.

Related tickers: APLS, ALPMY, CLSD.

Read Full Article
Trending Tickers

Please sign in to view